Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice.
- Published In:
- Physiology & behavior, 192, 72-81 (2018)
- Authors:
- Wismann, Pernille, Pedersen, Søren L, Hansen, Gitte, Mannerstedt, Karin, Pedersen, Philip J, Jeppesen, Palle B, Vrang, Niels, Fosgerau, Keld, Jelsing, Jacob
- Database ID:
- RPEP-03982
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03982APA
Wismann, Pernille; Pedersen, Søren L; Hansen, Gitte; Mannerstedt, Karin; Pedersen, Philip J; Jeppesen, Palle B; Vrang, Niels; Fosgerau, Keld; Jelsing, Jacob. (2018). Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice.. Physiology & behavior, 192, 72-81. https://doi.org/10.1016/j.physbeh.2018.03.004
MLA
Wismann, Pernille, et al. "Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice.." Physiology & behavior, 2018. https://doi.org/10.1016/j.physbeh.2018.03.004
RethinkPeptides
RethinkPeptides Research Database. "Novel GLP-1/GLP-2 co-agonists display marked effects on gut ..." RPEP-03982. Retrieved from https://rethinkpeptides.com/research/wismann-2018-novel-glp1glp2-coagonists-display
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.